Clinical Usability of Nasal Glucagon in Treatment of Hypoglycemia in Children and Adolescents
Clinical trial NCT02402933 · COMPLETED
Trial details
- NCT number
- NCT02402933
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2015-08-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.